Document is current
Any future updates will be listed below
-
Authors
Thompson, Jake R. https://orcid.org/0000-0002-0823-3218
Gomes, Lisa https://orcid.org/0009-0005-4004-3608
Kouvelis, Grace https://orcid.org/0000-0002-4116-383X
Smith, Andrea L. https://orcid.org/0000-0002-9194-4888
Lo, Serigne N. https://orcid.org/0000-0001-5092-5544
Kasparian, Nadine A. https://orcid.org/0000-0001-8075-6817
Saw, Robyn P. M. https://orcid.org/0000-0002-3354-806X
Dieng, Mbathio https://orcid.org/0000-0001-6714-9633
Seaman, Linda
Martin, Linda K. https://orcid.org/0000-0001-9519-7077
Guitera, Pascale https://orcid.org/0000-0001-9519-110X
Milne, Donna https://orcid.org/0000-0002-9874-2023
Schmid, Helen
Cust, Anne E. https://orcid.org/0000-0002-5331-6370
Bartula, Iris https://orcid.org/0000-0002-4084-4115
-
Funding
Funding for this research was provided by:
Melanoma Centre of Research Excellence
Melanoma Institute Australia
Heart Institute Research Core
Warwick L. Morison Professorship of Dermatology
National Health and Medical Research Council
- License Information
-
More Information
Article History
Received: 21 February 2025
Accepted: 17 December 2025
First Online: 27 December 2025
Declarations
:
: Ethics approval for this implementation study was granted by the Sydney Local Health District (Royal Prince Alfred Zone – 2020/ETH02518), protocol number: X20-0495. This study was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all individual participants included in the study.
: RPMS has received honoraria for advisory board participation from MSD and Australian Clinical Laboratories. DM has received honoraria for advisory board participation from MSD, BMS and Novartis and speaking honoraria from BMS and MSD. PG has received honoraria from Metaoptima, and travel stipend from L’Oreal. LKM has received speaking honorarium from AstraZeneca. SNL has received fees for professional services from SkylineDx and a stipend for editorial services at the British Journal of Dermatology.
: This study is registered with the Australia and New Zealand Clinical Trials Register (ACTRN12621000145808).
